Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection

Patients with colonic adenocarcinoma (COAD) are at relatively high risk of SARS-CoV-2 infection. However, there is a lack of medical strategies to treat COVID-19/COAD comorbidity. Puerarin, a natural product, is a known antiviral, antitumor, and immunomodulatory effect. Therefore, we hypothesised th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Weizheng, Li, Xiushen, Yao, Yue, Meng, Qingxue, Wu, Xueliang, Wang, Hao, Xue, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168431/
https://www.ncbi.nlm.nih.gov/pubmed/35677450
http://dx.doi.org/10.3389/fphar.2022.921517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168431/
https://www.ncbi.nlm.nih.gov/pubmed/35677450
http://dx.doi.org/10.3389/fphar.2022.921517

Ejemplares similares